Tempest Therapeutics
TPST
#10297
Rank
C$2.42 M
Marketcap
$0.69
Share price
-1.03%
Change (1 day)
-85.25%
Change (1 year)

EPS for Tempest Therapeutics (TPST)

EPS in 2023 (TTM): -$3.22

According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.29. In 2022 the company made an earnings per share (EPS) of -$4.51 an increase over its 2021 EPS that were of -$14.91.

EPS history for Tempest Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.22-28.73%
2022-$4.51-69.74%
2021-$14.91